Identification of the protein moiety of the LP(a)-lipoprotein in human plasma.

نویسندگان

  • D Seidel
  • H P. Geisen
  • D Roelcke
چکیده

The structure and function of plasma lipoproteins have received increasing attention in the past few years. The recognition of the importance of the protein moiety for the structural stability and metabolism of these conjugated macromolecules has stimulated this field of research and has emphasized the careful characterization of the apo-lipoproteins for a better understanding of lipid transport and metabolism. The classification and nomenclature in the lipoprotein field have been commonly based on two sets of operational terms. Differences in the hydrated density of plasma lipoproteins, which are largely a consequence of their lipid composition and differences in their electrophoretic mobility, which is primarily a consequence of their protein moiety, have provided the basis of a widely accepted classification system, comprising four major classes, each of which is characterized by a relatively narrow density range and a distinguished electrophoretic band. These are the very low density lipoproteins (VLDL; d < 1.006 g/ml), which can be further subdivided into chylomicrons and pre$lipoproteins, the low density lipoproteins (LDL; d 1.0061.063 g/ml) with P-mobility and the high density lipoproteins (HDL; d 1.0631.2 1 glml) exhibiting a-mobility on electrophoresis. Since we know more about the protein moeity of the piasma lipoproteins, the so-called apo-lipoproteins and their distribution between the different classes, so far three distinct are characterized (apo-A, apo-B and apo-C) each of which consists of subunits,

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

بررسی میزان لیپوپروتئین – آ در پلاسمای مبتلایان به دیابت نوع II

Introduction: Lipoprotein (a) is a particle rich in cholesterol in human plasma and it is known as an independent risk factor for coronary artery disease. In addition to genetic background, other factors such as diabetes affect the plasma concentration of this lipoprotein as a risk factor. The aim of this study was evaluation and comparison of plasma concentration of Lp(a) in type II diabetics ...

متن کامل

Effects of Conjugated Linoleic Acid Intake in the Form of Dietary Supplement or Enriched Food on C-Reactive Protein and Lipoprotein (a) Levels in Humans: A Literature Review and Meta-Analysis

Background: C-reactive protein (CRP) and lipoprotein (a) (Lp[a]) play essential roles in cardiovascular disease incidence. This study aimed to review the association between the intake of conjugated linoleic acid (CLA) in the form of dietary supplement or enriched food with different treatment durations and the levels of Lp(a) and CRP in human studies.Methods: All the articles published i...

متن کامل

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

Lp(a) is a plasma lipoprotein particle consisting of a plasminogenlike protein [apo(a)] disulfide bonded to the apo B moiety of low-density lipoprotein (LDL). Increased plasma levels of Lp(a), either independently or interactively with LDL levels, have been shown to be a risk factor for atherosclerosis. Recently, a new class of lipid-lowering drugs, HMG CoA reductase inhibitors, have been intro...

متن کامل

A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins.

The plasma low density lipoproteins (LDL) in biliary obstruction are characterized almost exclusively by the presence of the immunochemically distinct lipoprotein families, lipoprotein B (LP-B) and lipoprotein X (LP-X). It is suggested that LP-X, with its uniquely high content of unesterified cholesterol and phospholipid, is primarily responsible for the unusual lipid composition of LDL and the...

متن کامل

2034 Acute Reduction of Lipoprotein ( a ) by Tissue - Type Plasminogen Activator

Background. Lipoprotein(a) [Lp(a)] is a low density lipoprotein-like particle whose apolipoprotein B (apo B) moiety is disulfide-linked to apo(a), a plasminogen-like inhibitor of fibrinolysis in vitro. We hypothesized that plasma concentrations of Lp(a) are acutely affected by intravenous tissue-type plasminogen activator (t-PA). Methods and Results. Patients with unstable angina were randomize...

متن کامل

Acute reduction of lipoprotein(a) by tissue-type plasminogen activator.

BACKGROUND Lipoprotein(a) [Lp(a)] is a low density lipoprotein-like particle whose apolipoprotein B (apo B) moiety is disulfide-linked to apo(a), a plasminogen-like inhibitor of fibrinolysis in vitro. We hypothesized that plasma concentrations of Lp(a) are acutely affected by intravenous tissue-type plasminogen activator (t-PA). METHODS AND RESULTS Patients with unstable angina were randomize...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • FEBS letters

دوره 18 1  شماره 

صفحات  -

تاریخ انتشار 1971